| 16:00~16:10 | Welcome Remarks | 이문규 이사장 (성균관의대) |
| Session I | 좌장 : 이문규 (성균관의대), 백상홍 (가톨릭의대) |
Topic 1 "Great Footstep of Landmark Trials on the Dyslipidemia Treatment
(Statin Monotherapy vs. Combination Therapy)" |
| 16:10~16:30 | Overview of Landmark Randomized Statin Trials | 김성래 (가톨릭의대) |
| 16:30~16:50 | Fresh View of Landmark Trials Focused on Statin plus Other Agents | 최경묵 (고려의대) |
| 16:50~17:00 | Q&A, Discussion | All |
| Topic 2 Explore the Role of Statin in Atherosclerosis |
| 17:00~17:20 | The Impact of Intensive Statin Therapy on the Progression of Atherosclerosis (Both Quantity and Quality) | 최소연 (아주의대) |
| 17:20~17:30 | Q&A, Discussion | All |
| Topic 3 Current Status of Dyslipidemia Treatment in Korea |
| 17:30~17:45 | Current Status of Lipid-lowering Treatment in Pan-Asian Hypercholesterolaemic Patients | 성지동 (성균관의대) |
| 17:45~18:00 | Where Are We in Treating Korean Diabetic Dyslipidemia Patients? | 김신곤 (고려의대) |
| 18:00~18:10 | Q&A, Discussion | All |
| 18:10~19:00 | Dinner & Break | |
| Session II | 좌장 : 박경수 (서울의대), 고광곤 (가천의대) |
| Topic 4 Novel Approach to the Management of Dyslipidemia |
| 19:00~19:20 | DEFINE (Safety of Anacetrapib in Patiens with or at High Risk for Coronary Heart Disease) | 김상현 (서울의대) |
| 19:20~19:35 | ALPHA-OMEGA (n-3 Fatty Acids and Cardiovascular Events after Myocardial Infaction) | 김대중 (아주의대) |
| 19:35~19:50 | ASSERT (Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease) | 조상호 (한림의대) |
| 19:50~20:00 | Q&A, Discussion | All |
| Topic 5 Review of Current International Congress Hot Topics |
| 20:00~20:20 | New Insights Sharing Focused on Endocrinology International Congress | 권혁상 (가톨릭의대) |
| 20:20~20:40 | New Insights Sharing Focused on Cardiology International Congress | 윤창환 (서울의대) |
| 20:40~20:50 | Q&A, Discussion | All |
| 20:50~21:00 | Closing Remarks | 채성철 회장(경북의대) |
